Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 869,027 shares, a drop of 42.2% from the November 30th total of 1,502,780 shares. Currently, 8.2% of the company’s stock are short sold. Based on an average daily volume of 126,816 shares, the days-to-cover ratio is presently 6.9 days.
Separately, BidaskClub raised shares of Taro Pharmaceutical Industries from a “hold” rating to a “buy” rating in a research report on Thursday, September 28th.
Shares of Taro Pharmaceutical Industries (TARO) opened at $104.12 on Tuesday. Taro Pharmaceutical Industries has a 52 week low of $94.00 and a 52 week high of $128.46. The firm has a market cap of $4,178.63, a price-to-earnings ratio of 12.82 and a beta of 0.63.
WARNING: This piece was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2018/01/09/taro-pharmaceutical-industries-ltd-taro-short-interest-down-42-2-in-december.html.
Taro Pharmaceutical Industries Company Profile
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.
Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.